Merriman Capital Acted as Co-Manager in Avanir Pharmaceuticals, Inc.'s Follow-on Offering

by Benzinga Staff

November 23, 2010 2:56 PM | 14 seconds read |

Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc.

MERR

, acted as co-manager in Avanir Pharmaceuticals, Inc.'s

AVNR

$88 million follow-on offering of common stock at $4.40 per share. The transaction closed yesterday.

Posted In: News Offerings Financials Health Care Investment Banking & Brokerage Pharmaceuticals

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.